Included in this section:|
Chronic HBV Infection Study: A study of Entecavir in Blacks/African Americans and Hispanics with chronic HBV infection.
HIV Positive Women: An open-label, single arm study with stratification by CD4 cell count and HIV viral load to assess the immunogenicity, safety and tolerability of the quadrivalent human papillomavirus (HPV) recombinant vaccine (Gardasil) directed against virus types 6, 11, 16 and 18.
HIV/AIDS Promoting Maternal and Infant Survival Everywhere: The study at Rush University Medical Center in Chicago, Illinois, will screen and recruit pregnant or postpartum women on HIV meds for prevention of mother-to-child transmission of HIV.
Hepatitis C Study Using Antiviral Treatment: Study of a thrombopoietin receptor agonist, for 12 weeks in subjects with chronic hepatitis C-related thrombocytopenia who are potential candidates for antiviral treatment with pegylated interferon and ribavirin.
Policosonal for Dyslipidemia in HIV: The purpose of this study is to evaluate the safety and efficacy of a 12-week course of sugar cane-derived policosanol in a sample of 70 persons with HIV-related dyslipidemia.
Study Of TYZEKA with Compensated Chronic Hepatitis B Virus Infection: The purpose of this study is to estimate the proportion of patients who achieve non-detectable HBV DNA in black/Caribbean/African Americans and Hispanic/Latinos with compensated chronic hepatitis B during 24 weeks of treatment with telbivudine.
This study seeks to discover a primary treatment protocol for patients who are HIV positive and new to antiretroviral therapy.: This study seeks to discover a primary treatment protocol for patients who are HIV positive and new to antiretroviral therapy.
Three Non-NNRTI-Sparing Antiretroviral Regimens: The purpose of this study is to compare the effectiveness and tolerability of three combination FDA-approved HIV medication regimens using Truvada (emtricitabine/tenofovir disoproxil fumarate) as a base.